Bioceres Crop Solutions (NASDAQ:BIOX) Issues Earnings Results, Misses Estimates By $0.18 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) announced its earnings results on Wednesday. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.18), Zacks reports. The company had revenue of $53.80 million during the quarter. Bioceres Crop Solutions had a negative return on equity of 72.02% and a negative net margin of 105.94%.

Bioceres Crop Solutions Stock Down 4.6%

Shares of BIOX opened at $0.22 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 1.76. Bioceres Crop Solutions has a twelve month low of $0.19 and a twelve month high of $1.88. The company has a 50 day moving average of $0.31 and a 200-day moving average of $0.43.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions has a consensus rating of “Reduce” and an average price target of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.